Suppr超能文献

血小板反应蛋白与人类血小板的结合特性及其与血小板细胞骨架的关联

Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.

作者信息

Dubernard V, Legrand C

机构信息

Centre de Recherche sur l'Hémostase et la Thrombose Expérimentale de l'Association Claude Bernard, INSERM U 150, Hôpital Lariboisière, Paris, France.

出版信息

J Lab Clin Med. 1991 Nov;118(5):446-57.

PMID:1940585
Abstract

To characterize the interaction between thrombospondin and human platelets, thrombospondin was purified from the supernatant of thrombin-activated human platelets, labeled with iodine 125, and allowed to interact with the washed platelets. With concentrations of 10 to 50 micrograms/ml, only minute amounts of 125I-labeled thrombospondin bound to resting platelets or to platelets activated by adenosine diphosphate. In contrast, when platelets were stimulated with thrombin, binding increased fivefold to sixfold in a time-dependent and 125I-labeled thrombospondin concentration-dependent manner. Binding of 125I-labeled thrombospondin to thrombin-activated platelets required the presence of divalent cations, proceeded concomitantly with platelet release, and at a concentration of 1 nmol/L thrombin, reached a maximum of 2200 +/- 260 molecules of 125I-labeled thrombospondin bound per platelet. After its binding to platelets, 125I-labeled thrombospondin was not internalized, because up to 85% of the 125I-labeled thrombospondin was dissociated from the cell surface by adding ethylenediaminetetraacetic acid. Using various experimental approaches, including studies with severe type I thrombasthenic platelets, we further demonstrated that the interaction of 125I-labeled thrombospondin with thrombin-stimulated platelets occurred as a fibrinogen- and fibrin-independent process, and that the glycoprotein IIb-IIIa complex did not function as a physiologic plasma membrane receptor for 125I-labeled thrombospondin. Last, about 60% of the 125I-labeled thrombospondin molecules bound to the platelet surface were found to be associated with the platelet cytoskeleton recovered from platelets solubilized with Triton X-100. On Western blot analysis, this cytoskeletal fraction lacked detectable glycoprotein IV, the putative platelet receptor for thrombospondin. These results suggest that on the surface of thrombin-activated platelets, a fraction of 125I-labeled thrombospondin does not associate with glycoprotein IV but instead with other plasma membrane components that have yet to be identified.

摘要

为了表征血小板反应蛋白与人类血小板之间的相互作用,从凝血酶激活的人类血小板上清液中纯化出血小板反应蛋白,用碘125进行标记,并使其与洗涤后的血小板相互作用。在浓度为10至50微克/毫升时,只有微量的125I标记血小板反应蛋白与静息血小板或由二磷酸腺苷激活的血小板结合。相比之下,当用凝血酶刺激血小板时,结合量以时间依赖性和125I标记血小板反应蛋白浓度依赖性方式增加了五至六倍。125I标记血小板反应蛋白与凝血酶激活的血小板的结合需要二价阳离子的存在,与血小板释放同时进行,并且在凝血酶浓度为1纳摩尔/升时,每个血小板结合的125I标记血小板反应蛋白分子最多达到2200±260个。125I标记血小板反应蛋白与血小板结合后不会被内化,因为通过添加乙二胺四乙酸,高达85%的125I标记血小板反应蛋白会从细胞表面解离。使用各种实验方法,包括对严重I型血小板无力症血小板的研究,我们进一步证明125I标记血小板反应蛋白与凝血酶刺激的血小板之间的相互作用是一个不依赖纤维蛋白原和纤维蛋白的过程,并且糖蛋白IIb-IIIa复合物不是125I标记血小板反应蛋白的生理性质膜受体。最后,发现结合到血小板表面的125I标记血小板反应蛋白分子中约60%与用 Triton X-100溶解的血小板中回收的血小板细胞骨架相关。在蛋白质印迹分析中,这个细胞骨架部分缺乏可检测到的糖蛋白IV,即血小板反应蛋白的假定血小板受体。这些结果表明,在凝血酶激活的血小板表面,一部分125I标记血小板反应蛋白不与糖蛋白IV结合,而是与尚未确定的其他质膜成分结合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验